# InspireMD, Inc. (NSPR) · Edgar & Edgarette company card

> InspireMD (NSPR) grew revenue 28.1% in FY2025 to $9 million, operating margin -553% against a 1.2% median for surgical & medical instruments & apparatus, equity 79.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1433607 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NSPR) · [JSON](https://www.pops4.com/boards/company/NSPR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $9M |
| Revenue growth, 1 year | 28.1% |
| Revenue growth per year | 18.9% |
| Operating margin | -552.6% (prior year -478.0%) |
| Net margin | -543.3% |
| Operating cash flow | −$35M |
| Capital spending | $2M |
| Free cash flow | −$37M |
| Cash | $9M |
| Long-term debt | — |
| Total assets | $69M |
| Total equity | $55M |
| Equity ÷ assets | 79.5% |
| Return on equity | -88.4% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -10.12 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -3.37 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -552.6% in FY2025; revenue is hard to predict: its 80% range is ±55%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $9.0M (FY2025). Experience: revenue up 28.1% on the year, up 18.9% a year over 4 years; operating margin -552.6%, down from -478.0%. Soundness: equity 79.5% of assets, return on equity -88.4%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $5.9M and $20.2M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $5.5M to $22.0M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -552.6% against a 1.2% median; growth 28.1% against 11.6%.

Range logged 2026-09-26, receipt 7894ae3dd3f5f7e5, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-07-23 ([filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226034430/0001493152-26-034430-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-07-29 ([filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226035220/0001493152-26-035220-index.htm))

## Recent filings

- 8-K · filed 2026-09-21 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/0001493152-26-043488-index.htm)
- 8-K · filed 2026-08-17 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226038624/0001493152-26-038624-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226038438/0001493152-26-038438-index.htm)
- 8-K · filed 2026-07-29 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226035220/0001493152-26-035220-index.htm)
- 8-K · filed 2026-07-23 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226034430/0001493152-26-034430-index.htm)
- 8-K · filed 2026-07-02 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1433607/000149315226031945/0001493152-26-031945-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001433607.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1433607

## Cite

POPS4, Edgar & Edgarette: InspireMD, Inc. (NSPR) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/NSPR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.